Increased activation of key oncogenic signalling pathways (PI3K/AKT, RAS/MAPK and MYC) upstream of ribosome biogenesis constitutes yet another hallmark of HGSC,nine and we hypothesise that inhibiting ribosome biogenesis can offer a powerful cancer therapeutic alternative.10 In truth, We've revealed encouraging responses While using the ribosomal RN